ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Releases Digestive Diseases Research Plan

May 1, 2009

Two View Mammography Said Less Costly Than One In Screening

April 25, 1986

A Provision Of The EARLY Bill Is Inserted Into House Appropriations For Labor, HHS

July 24, 2009

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

Survival For ALL Increased To 94 Percent In Recent Years

December 31, 2010